Immunoclin Corp
CIK 0001520047
Revenue (TTM)
$5K
Q3 Dec 2014
Net Income (TTM)
−$7.97M
−3,840,230.5% YoY
Q3 Dec 2014
EPS Diluted (TTM)
—
Q3 Dec 2014
Gross Margin
—
Q3 Dec 2014
Operating Margin
-164,209.7%
Q3 Dec 2014
Net Margin
-159,445.0%
Q3 Dec 2014
Free Cash Flow (TTM)
−$158.9K
Q3 Dec 2014
Cash
$23
Q3 Dec 2014
Total Debt
—
Q3 Dec 2014
Shares Outstanding
28.83M sh
Q3 Dec 2014
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.